Valaris Schedules Second Quarter 2025 Earnings Release and Conference Call
The conference call will be webcast live at www.valaris.com. Alternatively, callers may dial +1-855-239-3215 within the United States or +1-412-542-4130 from outside the U.S. It is recommended that participants call 10 minutes prior to the scheduled start time.
A webcast replay and transcript of the call will be available on the Company's website. A replay will also be available through August 31, 2025, by dialing +1-877-344-7529 within the United States or +1-412-317-0088 from outside the U.S. (conference ID 1556736).
Valaris uses its website to disclose material and non-material information to investors, customers, employees and others interested in the Company. To receive regular updates on Valaris news or SEC filings, please sign-up for Email Alerts on the Company's website.
About Valaris Limited
Valaris Limited (NYSE: VAL) is the industry leader in offshore drilling services across all water depths and geographies. Operating a high-quality rig fleet of ultra-deepwater drillships, versatile semisubmersibles and modern shallow-water jackups, Valaris has experience operating in nearly every major offshore basin. Valaris maintains an unwavering commitment to safety, operational excellence, and customer satisfaction, with a focus on technology and innovation. Valaris Limited is a Bermuda exempted company (Bermuda No. 56245). To learn more, visit our website at www.valaris.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Ford Keeps Disappointing Investors in This Key Factor -- and 1 Graph You Have to See
Key Points Ford's 90 recalls so far in 2025 already sets a record. Recalls don't typically impact auto stocks, but there are exceptions. This recall will incur a special item on earnings, not impacting adjusted earnings. 10 stocks we like better than Ford Motor Company › Ford Motor Company (NYSE: F) is known for many things, including championing the moving assembly line that drastically changed the automotive industry in its infancy. It's also known for its lucrative dividend, trudging through the financial crisis without a government bailout, and producing more vehicles in the U.S. than its Detroit rivals. Unfortunately, Ford is also becoming known for something less desirable: recalls and warranty costs, and it's been a problem for years. Let's take a look at Ford's recent recall and how much it'll dent earnings. Recalls. Recalls everywhere. Let's first make a note of something: Recalls are simply a part of business in the automotive industry. Typically, recalls don't tend to impact automotive stocks. In fact, when the vehicle is sold the automaker essentially estimates what the future cost of warranty coverage will be, and sets aside cash to handle such business. The problem is when warranty costs exceed, or greatly exceed, original estimates -- that's when excess costs can add up and weigh on the bottom line. That said, Ford's recent recall for nearly 700,000 crossovers in the U.S., due to a fuel leak issue that could increase the risk of a fire, is the automaker's 90th recall already in 2025 -- a staggering number. Ford's 90 recalls so far this year are more than the next five manufacturers combined, and already set a full-year record for an individual automaker, breaking General Motors' previous record of 77 recalls in 2014 amid its massive ignition switch scandal, according to the National Highway Traffic Safety Administration (NHTSA). To be fair, not all recalls are created equal, and issues that can be fixed with an over-the-air software update hardly cost the company a thing. On the flip side, when a vehicle has to be serviced, parts adjusted, or other manual labor is required, expenses can add up fast. So it's a bit unfair to draw any drastic conclusions solely from 90 recalls without knowing further details. Ford said 33 of its recalls so far in 2025 were related to software audits implemented in March, which should be far less costly than other recalls. If you recall (no pun intended), last year during the second quarter warranty costs checked in $800 million higher compared to the prior year, which caused Ford to miss earnings and sent its stock lower. This recent recall shouldn't cause a similar result, for the most part. What's the damage? Ford said the recall remedy will cost the company roughly $570 million and will be included in the second-quarter earnings report as a "special item." For investors, this means that the increase in warranty expenses won't impact the company's adjusted earnings (which is what Wall Street estimates), adjusted earnings per share (EPS), or adjusted free cash flow. In the early 2000s Ford's warranty payments compared to revenue was at a much lower percentage. That spiked to about 4% during last year's second quarter, a high number for automakers, when the company notoriously took a hit for higher warranty costs. Let's look at some longer trends. Here are Ford's warranty payments as a percentage of revenue over the past 20 years. For a quick comparison, rival General Motors' warranty payments as a percentage of revenue checked in at 2.4% and 2.3% in 2024 and 2023, respectively. Ford has stood firm that it's making significant quality improvements and noted that 2024 model years, during the first three months of service, were 30% better in quality compared to prior years. Currently, Ford's warranty costs and quality issues are one of the biggest uncertainties facing investors. Ford is saying all the right things, and supposedly doing all the right things to fix quality, but so far investors have been left disappointed. It's certainly something to note in your Ford investment thesis, and recalls and warranty costs will be something to keep your eye on over the next 18 months as, hopefully, quality improvements filter through and recalls decline. Should you buy stock in Ford Motor Company right now? Before you buy stock in Ford Motor Company, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Ford Motor Company wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Daniel Miller has positions in Ford Motor Company. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Ford Keeps Disappointing Investors in This Key Factor -- and 1 Graph You Have to See was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
30 minutes ago
- Yahoo
Why Eli Lilly (LLY) is Emerging as a Dividend Growth Leader in Pharma for 2025
Eli Lilly and Company (NYSE:LLY) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. An array of pharmaceutical pills with the company's logo on the bottle. In the past five years, the company has raised its payouts at an annual average rate of 16%. Its consistent track record makes it an appealing choice for investors focused on dividend growth, especially given the strength of its broader operations. A company's ability to sustain dividends depends on its overall stability, and Eli Lilly stands out as one of the most solid players in the pharmaceutical space today. It holds a leading position in the rapidly expanding weight loss segment. Eli Lilly and Company (NYSE:LLY) also has a promising pipeline, with several potential blockbuster drugs that could each generate over $1 billion in annual revenue. Its revenue and earnings have been rising at a pace that surpasses many of its peers, a trend expected to continue in the coming years. As a result, investors who remain patient could benefit from steady dividend increases as well as long-term stock gains. On June 23, Eli Lilly and Company (NYSE:LLY) declared a quarterly dividend of $1.50 per share, which was in line with its previous dividend. Overall, the company has been growing its payouts for 11 consecutive years. As of July 17, the stock has a dividend yield of 0.77%. While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Sign in to access your portfolio
Yahoo
35 minutes ago
- Yahoo
Pfizer's (PFE) Dividend Safety: Balancing Innovation and Shareholder Returns
Pfizer Inc. (NYSE:PFE) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. A medical technician wearing protective gloves and a mask mixing a biopharmaceutical solution. Pfizer Inc. (NYSE:PFE) hasn't performed well in recent years, with its stock declining more than 26% over the past decade. However, the outlook appears brighter, thanks to its strong pipeline of drugs currently in development. Much of the negative sentiment seems to be already reflected in its depressed share price. Recently, the company's forward P/E ratio stood at 8.3, which is noticeably lower than its five-year average of 10.2. Pfizer Inc. (NYSE:PFE) reported mixed earnings in the first quarter of 2025. The company posted revenue of $13.7 billion, down 8% on a YoY basis. The revenue also missed analysts' estimates of $335.8 million; however, its EPS of $0.92 beat the consensus by $0.25. The company noted that its emphasis on operational efficiency and financial discipline has been contributing positively to its bottom line. It further stated that performance is currently tracking toward the higher end of its 2025 adjusted diluted EPS guidance range. Pfizer Inc. (NYSE:PFE)'s strong balance sheet allowed it to return $2.4 billion to shareholders through dividends during the quarter. The company has raised its payouts for 15 years in a row. It offers a quarterly dividend of $0.43 per share and has a dividend yield of 7.03%, as of July 17. While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Sign in to access your portfolio
